These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2026012)

  • 1. Consensus conference. Treatment of early stage breast cancer. National Institutes of Health.
    Conn Med; 1991 Feb; 55(2):101-7. PubMed ID: 2026012
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma.
    Lazovich D; Solomon CC; Thomas DB; Moe RE; White E
    Cancer; 1999 Aug; 86(4):628-37. PubMed ID: 10440690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus statement: treatment of early-stage breast cancer. National Institutes of Health Consensus Development Panel.
    J Natl Cancer Inst Monogr; 1992; (11):1-5. PubMed ID: 1627416
    [No Abstract]   [Full Text] [Related]  

  • 4. Consensus conference 2000: adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement November 1-3, 2000.
    Cancer Control; 2001; 8(1):55. PubMed ID: 11176036
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant chemotherapy for breast cancer. National Institutes of Health Consensus Development Conference Statement.
    Natl Inst Health Consens Dev Conf Consens Statement; 1985; 5(12):5 p.. PubMed ID: 3908920
    [No Abstract]   [Full Text] [Related]  

  • 6. [Conservative treatment of breast epitheliomas. Retrospective study of a series of 370 cases (1963-1974)].
    Reboul F; Serin D; Martin P; Pouzin C; Reboul G
    Ann Chir; 1983 Sep; 37(6):393-401. PubMed ID: 6638883
    [No Abstract]   [Full Text] [Related]  

  • 7. [A survey on breast conservation modalities in cancer institutes].
    Langlois D
    Bull Cancer; 1990; 77(8):793-7. PubMed ID: 2207368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quality of care for treatment of early stage breast carcinoma: is it consistent with national guidelines?
    Guadagnoli E; Shapiro CL; Weeks JC; Gurwitz JH; Borbas C; Soumerai SB
    Cancer; 1998 Jul; 83(2):302-9. PubMed ID: 9669813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The National Institutes of Health Consensus Development Conference: Adjuvant Therapy for Breast Cancer. Bethesda, Maryland, USA. November 1-3, 2000. Proceedings.
    J Natl Cancer Inst Monogr; 2001; (30):1-152. PubMed ID: 12083020
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of breast cancer--change from radical to quality-controlled individualized treatment].
    Fink D; Kimmig R; Winter R
    Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):125-6. PubMed ID: 15990435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy of breast cancer. National Institutes of Health Consensus Development Conference Summary, Volume 3, Number 3.
    Oncol Nurs Forum; 1981; 8(1):7-9. PubMed ID: 7003562
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence.
    Blakely LJ; Buzdar AU; Lozada JA; Shullaih SA; Hoy E; Smith TL; Hortobagyi GN
    Cancer; 2004 Feb; 100(3):465-9. PubMed ID: 14745861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer.
    Stuart RK
    Trans Assoc Life Insur Med Dir Am; 1989; 72():134-43. PubMed ID: 2662561
    [No Abstract]   [Full Text] [Related]  

  • 15. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
    Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
    Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast-conserving therapy in breast cancer].
    Marcollet A; Doridot V; Nos C
    Rev Prat; 2004 Apr; 54(8):847-53. PubMed ID: 15274458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative analysis of combined and complex methods of the treatment of stage IIIb breast cancer].
    Demidov VP; Borisov VI; Ivanov OA
    Vopr Onkol; 1990; 36(12):1473-9. PubMed ID: 2288126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim results of treatment of breast cancer with breast conservation for all patients.
    Bulman AS; Zeitman A; Phillips RH; Ellis H
    Surgery; 1987 Apr; 101(4):395-9. PubMed ID: 3563884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited surgery with or without radiotherapy for early breast carcinoma.
    Freeman CR; Belliveau NJ; Kim TH; Boivin JF
    J Can Assoc Radiol; 1981 Jun; 32(2):125-8. PubMed ID: 7251618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
    Meric F; Mirza NQ; Vlastos G; Buchholz TA; Kuerer HM; Babiera GV; Singletary SE; Ross MI; Ames FC; Feig BW; Krishnamurthy S; Perkins GH; McNeese MD; Strom EA; Valero V; Hunt KK
    Cancer; 2003 Feb; 97(4):926-33. PubMed ID: 12569592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.